Helex is taking the promise of non-viral targeted delivery and genome editing to the kidney, developing first-in-class genetic medicines for renal indications. Helex combines its proprietary kidney tropic lipid nanoparticle delivery system with the Epic-Cure(TM) 3D genome-based drug designer platform to create a robust renal franchise of precise and scalable therapeutics. Our lead asset is a mutation-agnostic, potential one-and-done therapy for Autosomal Dominant Polycystic Kidney Disease that impacts over 4 million people worldwide.
| Website | http://www.helex.bio |
| Employees | 32 (15 on RocketReach) |
| Founded | 2021 |
| Address | 180 Varick St, New York, New York 10014, US |
| Industry | Biotechnology |
| Keywords | Gene Therapy, Genome Editing, Renal Disease, Kidney Disease, Genetic Medicine, Drug Delivery, Lipid Nanoparticles, Nanoparticle Drug Delivery, Targeted Drug Delivery, Therapeutic Delivery, Biotechnology, Pharmaceutical, Clinical Trials, Preclinical Development, Molecular Medicine, Rare Diseases |
| Competitors | Roche, Thermo Fisher Scientific, Illumina, Celerion, BGI Genomics, PacBio, 10x Genomics, QIAGEN, BioDuro-Sundia, Genapsys +40 more (view full list) |
Looking for a particular Helex employee's phone or email?
Helex Questions
Rohini Kalvakuntla is the Co-Founder and Chief Business Officer of Helex.
15 people are employed at Helex.
Helex is based in New York, New York.
Top Helex Employees
-
Rohini Kalvakuntla
Co-Founder and Chief Business Officer at Helex
New York, NY, US22 -
Anirudh Nishtala
Chief Operating Officer at Helex
Telangana, India21 -
1
-
Suman Alishetty
VP of Drug delivery at Helex
Manassas, VA, US -
Yogendra Verma
Scientist, Molecular Biology at Helex
Millbrae, CA, US11 -
1
-
Harsha Rohira
Lead Scientist, Drug Delivery at Helex
Delhi, India1 -
Gayathri Sembara
Junior Scientist at Helex
Hyderabad, IN1 -
Yugantak Gupta
Junior Research Scientist at Helex
Hyderabad, IN
